Form D — Gaius Therapeutics, Inc,
0002132841-26-000002 · filed May 14, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $250,000
- Total sold
- $60,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Gaius Therapeutics, Inc,
- CIK
- 2132841
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 9276 SCRANTON ROAD, SUITE 500
SAN DIEGO, CA 92121 - Phone
- 650-255-8226
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jesse Joseph Solvason · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Adam Klie · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Javid Aceil · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Ben Wang · DirectorSan Diego, CA Find on LinkedIn ↗
-
Christopher Emig · DirectorSan Diego, CA Find on LinkedIn ↗
-
Michon Pinnix · DirectorSan Diego, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗